Dajiang Guo

Prof. Dr. Dajiang Guo

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2018 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
DGDajiang Guo
Dajiang Guo
GLGoldie Y.L. Lui
Goldie Y.L. Lui
SLSiew Li Lai
Siew Li Lai
JWJames Wilmott
James Wilmott
STShweta Tikoo
Shweta Tikoo
KBKimberley A. Beaumont
Kimberley A. Beaumont

1 December 2021 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
JLJianhuang Lin
Jianhuang Lin
DGDajiang Guo
Dajiang Guo
HLHeng Liu
Heng Liu
WZWei Zhou
Wei Zhou
CWChen Wang
Chen Wang
RZRugang Zhang
Rugang Zhang
The tumor immune microenvironment is influenced by the epigenetic landscape of the tumor. Here, we have identified the SETDB1–TRIM28 complex as a critical suppressor of antitumor immunity. An epigenetic CRISPR–Cas9 screen of 1,218 chromatin regulators identified TRIM28 as a suppressor of PD-L1 expression. We then revealed that expression of the SETDB1–TRIM28 complex negatively correlated with infiltration of effector CD8+ T cells. Inhibition of SETDB1–TRIM28 simultaneously upregulated PD-L1 and activated the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) innate immune response pathway to increase infiltration of CD8+ T cells. Mechanistically, SETDB1–TRIM28 inhibition led to micronuclei formation in the cytoplasm, which is known to activate the cGAS–STING pathway. Thus, SETDB1–TRIM28 inhibition bridges innate and adaptive immunity. Indeed, SETDB1 knockout enhanced the antitumor effects of immune checkpoint blockade with anti–PD-L1 in a mouse model of ovarian cancer in a cGAS-dependent manner. Our findings establish the SETDB1–TRIM28 complex as a regulator of antitumor immunity and demonstrate that its loss activates cGAS–STING innate immunity to boost the antitumor effects of immune checkpoint blockade.

7 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJianhuang Lin
Jianhuang Lin
HLHeng Liu
Heng Liu
TFTakeshi Fukumoto
Takeshi Fukumoto
JZJoseph Zundell
Joseph Zundell
QYQingqing Yan
Qingqing Yan
RZRugang Zhang
Rugang Zhang
CARM1 is often overexpressed in human cancers including in ovarian cancer. However, therapeutic approaches based on CARM1 expression remain to be an unmet need. Cancer cells exploit adaptive responses such as the endoplasmic reticulum (ER) stress response for their survival through activating pathways such as the IRE1α/XBP1s pathway. Here, we report that CARM1-expressing ovarian cancer cells are selectively sensitive to inhibition of the IRE1α/XBP1s pathway. CARM1 regulates XBP1s target gene expression and directly interacts with XBP1s during ER stress response. Inhibition of the IRE1α/XBP1s pathway was effective against ovarian cancer in a CARM1-dependent manner both in vitro and in vivo in orthotopic and patient-derived xenograft models. In addition, IRE1α inhibitor B-I09 synergizes with immune checkpoint blockade anti-PD1 antibody in an immunocompetent CARM1-expressing ovarian cancer model. Our data show that pharmacological inhibition of the IRE1α/XBP1s pathway alone or in combination with immune checkpoint blockade represents a therapeutic strategy for CARM1-expressing cancers.

1 November 2018 in Cell Reports
Verified
Journal Article
Open access
DZDetu Zhu
Detu Zhu
ZZZuxianglan Zhao
Zuxianglan Zhao
GCGuimei Cui
Guimei Cui
SCShiehong Chang
Shiehong Chang
LHLingling Hu
Lingling Hu
ECEdwin Cheung
Edwin Cheung
Estrogen drives breast cancer (BCa) progression by directly activating estrogen receptor α (ERα). However, because of the stochastic nature of gene transcription, it is important to study the estrogen signaling pathway at the single-cell level to fully understand how ERα regulates transcription. Here, we performed single-cell transcriptome analysis on ERα-positive BCa cells following 17β-estradiol stimulation and reconstructed the dynamic estrogen-responsive transcriptional network from discrete time points into a pseudotemporal continuum. Notably, differentially expressed genes show an estrogen-stimulated metabolic switch that favors biosynthesis but reduces estrogen degradation. Moreover, folate-mediated one-carbon metabolism is reprogrammed through the mitochondrial folate pathway and polyamine and purine synthesis are upregulated coordinately. Finally, we show AZIN1 and PPAT are direct ERα targets that are essential for BCa cell survival and growth. In summary, our study highlights the dynamic transcriptional heterogeneity in ERα-positive BCa cells upon estrogen stimulation and uncovers a mechanism of estrogen-mediated metabolic switch.

1 October 1998 in Journal of Business & Economic Statistics
Verified
Journal Article
Closed access
DGDajiang Guo
Dajiang Guo

1 July 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
DGDajiang Guo
Dajiang Guo
RJRohit Jain
Rohit Jain
JHJae Sung Hwang
Jae Sung Hwang
WWWolfgang Weninger
Wolfgang Weninger
KBKimberley A. Beaumont
Kimberley A. Beaumont
STShweta Tikoo
Shweta Tikoo